Company Profile

CYIENT LTD.

NSE : CYIENTBSE : 532175ISIN CODE : INE136B01020Industry : IT - Software House : Cyient
BSE219.900.95 (+0.43 % )
PREV CLOSE (Rs.) 218.95
OPEN PRICE (Rs.) 221.65
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 17529
TODAY'S LOW / HIGH (Rs.)219.05 227.25
52 WK LOW / HIGH (Rs.)205 635
NSE219.55 0.75 (+0.34 % )
PREV CLOSE(Rs.) 218.80
OPEN PRICE (Rs.) 222.70
BID PRICE (QTY) 219.55 (85 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 562820
TODAY'S LOW / HIGH(Rs.) 218.80 225.40
52 WK LOW / HIGH (Rs.)210 636.65

Company News

Date Heading Details
03-Apr-2020 Cyient provides drone-based surveillance technology to Telangana state police <p align="justify">Cyient has been providing Telangana State Police with drone-based surveillance technology to help implement the COVID-19 related lockdown in Hyderabad. The technology is enabling the Police make lockdown-related announcements and organize their ground forces to monitor the situation in congested areas of the city.</p><p align="justify">Equipped with surveillance cameras, thermal imaging payloads and sky speaker for public announcements, Cyient's drone-based aerial inspection capability is positively augmenting the police's ability to combat the spread of the pandemic. By providing situational awareness on a real-time basis, the technology gives Police the means to understand and deploy resources very quickly to manage evolving situations.</p><p align="justify">Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.<br></p>
03-Apr-2020 Cyient to partner with Hitachi Rail to accelerate signaling technology deployment <div align="justify">Cyient has signed an agreement with Hitachi Rail to deliver a series of project engineering services to support Hitachi Rail accelerate the evolution of its signaling technology and expand and enhance its project execution capacity. <br><br></div><div align="justify">The company will develop and operate a Central Delivery Center for Hitachi Rail in India, and a Regional Center in the US. These centers will be responsible for delivering engineering services for Hitachi's global signaling projects that use proprietary interlocking platforms. They will also provide software development and configuration support for Hitachi's ATS product. <br><br></div><div align="justify">The company will combine its global footprint, scale, and deep domain experience of over 16 years with Hitachi Rail's vision and extensive technical expertise. The partnership will enable safer design and operations as well as ensure critical benefits to rail operators across the globe.</div><div align="justify"><br></div><div align="justify">Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.<br><br></div>
03-Apr-2020 Cyient informs about press release <P align=justify>Cyient has informed that a copy of a press release being issued by the company is enclosed titled 'Cyient to Partner with Hitachi Rail to Accelerate Signaling Technology Deployment'.<P>The above information is a part of company's filings submitted to BSE.<BR>
03-Apr-2020 Reliance Industries, Majesco and Earum Pharmaceuticals to see some action today <p align="justify"><strong>Reliance Industries'</strong> board has approved the proposal for raising funds through issuance of Non-Convertible Debentures (NCDs) up to Rs 25,000 crore in tranches from time to time, on a private placement basis. The Board of Directors of the company at its meeting held on April 2, 2020 has approved the same. </p><p align="justify"><strong>Majesco</strong> has completed the acquisition of InsPro Technologies Corporation, a U.S. based software leader in the life and annuity insurance market. InsPro Technologies brings an insurance administration and marketing system that supports group and individual business lines, and efficiently processes agent, direct market, worksite and website generated business. </p><p align="justify"><strong>Earum Pharmaceuticals'</strong> board has approved to acquire Cedac Medicorp a partnership firm engaged in manufacturing of Pharmaceutical products. The company proposes to enter into an agreement to acquire its 55% stake i.e. of the partnership firm Cedac Medicorp manufacture's pharmaceutical products since its formation in 2017 and Cedac Medicorp is located at Ahmedabad. The Board Members of company in their meeting held on April 2, 2020, has considered and approved the same.</p><p align="justify"><strong>Cyient</strong> has been providing Telangana State Police with drone-based surveillance technology to help implement the COVID-19 related lockdown in Hyderabad. The technology is enabling the Police make lockdown-related announcements and organize their ground forces to monitor the situation in congested areas of the city.</p><p align="justify"><strong>Indian Bank</strong> has launched three emergency credit facilities for the agriculture sector which has been affected by the nationwide lockdown on account of Covid-19. The lender is providing funding to agri-processing units, which can avail loans up to 10 percent of their working capital limit.&nbsp;Borrowers in the poultry segment can avail loans to a maximum of 20 percent of their working capital limit and farmers cultivating crops / rearing animals and having KCC facility can avail 10 percent of the limit as soft loan.&nbsp;&nbsp; </p><p align="justify"><strong>Sunshield Chemicals</strong> has commenced operations at Rasal Plant in Antioxidant division. The company will follow all the precautions necessary to ensure safety and well-being of its employees in its plant.</p><p align="justify"><strong>Cipla</strong> has successful completed Phase-3 clinical end-point study for fluticasone propionate and salmeterol inhalation powder (100/50 mcg). Fluticasone propionate and salmeterol inhalation powder 100/50 mcg, 250/50 mcg and 500/50 mcg are generic versions of GSK's Advair Diskus. <br></p>
01-Apr-2020 Cyient trades higher on the BSE <p align="justify">Cyient is currently trading at Rs. 239.30, up by 9.65 points or 4.20% from its previous closing of Rs. 229.65 on the BSE.</p><p align="justify">The scrip opened at Rs. 235.00 and has touched a high and low of Rs. 239.35 and Rs. 229.00 respectively. </p><p align="justify">The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 645.00 on 02-Apr-2019 and a 52 week low of Rs. 205.00 on 25-Mar-2020.</p><p align="justify">Last one week high and low of the scrip stood at Rs. 250.00 and Rs. 216.00 respectively. The current market cap of the company is Rs. 2525.49 crore.</p><p align="justify">The promoters holding in the company stood at 22.82%, while Institutions and Non-Institutions held 65.24% and 11.94% respectively.</p><p align="justify">Cyient has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19. </p><p align="justify">The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India.</p><p align="justify">Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.</p><p align="justify"><br></p>
31-Mar-2020 Cyient receives clearance for Mysore facility <DIV align=justify>Cyient has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19. <BR><BR></DIV><DIV align=justify>The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India.<BR><BR></DIV><DIV align=justify>Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.<BR><BR></DIV>
31-Mar-2020 Cyient shines on receiving clearance for Mysore facility <p align="justify">Cyient is currently trading at Rs. 226.05, up by 8.50 points or 3.91% from its previous closing of Rs. 217.55 on the BSE.</p><p align="justify">The scrip opened at Rs. 217.55 and has touched a high and low of Rs. 232.20 and Rs. 217.50 respectively. So far 5410 shares were traded on the counter.</p><p align="justify">The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 658.00 on 01-Apr-2019 and a 52 week low of Rs. 205.00 on 25-Mar-2020.</p><p align="justify">Last one week high and low of the scrip stood at Rs. 250.00 and Rs. 205.00 respectively. The current market cap of the company is Rs. 2392.42 crore.</p><p align="justify">The promoters holding in the company stood at 22.82%, while Institutions and Non-Institutions held 65.24% and 11.94% respectively.</p><p align="justify">Cyient has received clearance for its Mysore facility to run its MedTech manufacturing lines to support the production of medical equipment that is critical in the fight against COVID-19.</p><p align="justify">The company is producing assemblies that are used in X-ray generators from GE Healthcare and diagnosis units from Molbio Diagnostics to enable rapid disease testing in India.</p><p align="justify">Cyient provides engineering, manufacturing, geospatial, network and operations management services to global industry leaders. It leverages the power of digital technology and advanced analytics capabilities, along with domain knowledge and technical expertise, to solve complex business problems.</p>
13-Mar-2020 Announcement under Regulation 30 (LODR)-Date of payment of Dividend The date payment for the 2nd interim dividend is 30 March 2020.
13-Mar-2020 Corporate Action-Board approves Dividend We would like to inform you that at the Board Meeting held today, the Directors have declared a 2nd Interim dividend of Rs. 9/- per equity share (i.e. 180 %) on par value of Rs. 5/- per share for the financial year 2019-20.
13-Mar-2020 Declaration Of 2Nd Interim Dividend For FY 2019-20 And Intimation Of Record Date We would like to inform you that at the Board Meeting held today, the Directors have declared a 2nd Interim dividend of Rs. 9/- per equity share (i.e. 180 %) on par value of Rs. 5/- per share for the financial year 2019-20.